NEW YORK, Nov. 21, 2016 /PRNewswire-USNewswire/ -- Released today, Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health identified alcohol and drug misuse and substance use disorders as the most pressing public health concern facing America. The release of Thursday's landmark report marks the first time a U.S. Surgeon General has dedicated a report to substance misuse and related disorders. The report addresses alcohol, illicit drugs and prescription drug misuse, with chapters dedicated to neurobiology, prevention, treatment, recovery, health systems integration and recommendations for the future. It provides an in-depth look at the science of substance misuse and addiction, calls for a cultural shift in the way Americans talk about the issue, and recommends actions we can all take collectively to prevent and treat these conditions, and promote recovery. Partnership for Drug-Free Kids applauds the Surgeon General's recommendations to take a comprehensive, public health approach to addressing substance use in our society. The Surgeon General's report is being issued at a critical time, when our country is in the throes of a national opioid addiction epidemic: between 1999 and 2014, approximately 193,000 Americans died from causes related to prescription opioids, and we know that three out of four current heroin users previously misused prescription pain relievers. Attention was brought to the role that prescribers can play in addressing this health crisis when the Surgeon General issued a letter this past August to more than 2 million healthcare providers urging them to help turn the tide of opioid abuse problems facing the nation. Among key actions that prescribers can take to help curb the national opioid abuse problem, the Surgeon General's report issued on Thursday calls for increasing prescribers' awareness of and compliance with the most recent federal guidelines for opioid prescribing, expanding the use of evidence-based treatments and effective integration of prevention and treatment services, and reliance on the use of prescription drug monitoring programs by healthcare providers.